Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Depreciation & Amortization (CF) (2020 - 2025)

Gain Therapeutics has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $28241.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $28241.0 for Q4 2025, up 32.54% from a year ago — trailing twelve months through Dec 2025 was $94046.0 (up 11.86% YoY), and the annual figure for FY2025 was $94046.0, up 11.86%.
  • Depreciation & Amortization (CF) for Q4 2025 was $28241.0 at Gain Therapeutics, up from $22817.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for GANX hit a ceiling of $28241.0 in Q4 2025 and a floor of $2158.0 in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $20374.0 (2023), compared with a mean of $17067.4.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 827.76% in 2022 and later dropped 9.67% in 2024.
  • Gain Therapeutics' Depreciation & Amortization (CF) stood at $5788.0 in 2021, then surged by 212.89% to $18110.0 in 2022, then skyrocketed by 30.25% to $23589.0 in 2023, then fell by 9.67% to $21307.0 in 2024, then skyrocketed by 32.54% to $28241.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $28241.0 (Q4 2025), $22817.0 (Q3 2025), and $22328.0 (Q2 2025) per Business Quant data.